NASDAQ
Astellas Pharma Inc. (ALPMF) has a free cash flow growth of 211.26% as of Friday, May 29, 2026. This represents a 21.76% increase compared to its 12-month average of 173.50%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.